PHARMAJET, INC.

GOLDEN, CO · Founded 2005 · Medtech · Private

Needle-free intradermal injection device for HPV vaccine delivery

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
GOLDEN, CO
Founded
2005
Latest Form D
$15.4M, Apr 2021
Total capital
$49M
Federal grants
$844K
2 awards · 2022–2023
Rank in peer group#38 of 445
Private capital raised
$48.2M
14 Form D · last Apr 2021
66 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
14 pending · first 2013
Rank in peer group#12 of 445

Capital timeline

20092011201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $53.5M$738K$106K14th Form D$15.4M
2009201320172021FEDERAL ↑EQUITY ↓Cumulative $53.5M$738K$106K

Latest events

  • Federal grantHealth and Human S · Phase II · Translational Use of Intradermal Needle-free Injector to facilitate and optimize global fractional dose HPV vaccine administration$106K
  • Federal grantHealth and Human S · Phase II · Translational Use of Intradermal Needle-free Injector to facilitate and optimize global fractional dose HPV vaccine administration$738K
  • Private capital raisedForm D · SEC · 14th filing$15.4M
  • Private capital raisedForm D · SEC · 13th filing$3M
  • Private capital raisedForm D · SEC · 12th filing$1.8M
  • Private capital raisedForm D · SEC · 11th filing$3M
  • Private capital raisedForm D · SEC · 10th filing$3.7M
  • Offering registeredForm D · SEC · 9th filing$3M
  • Offering registeredForm D · SEC · 8th filing$1.5M
  • Private capital raisedForm D · SEC · 7th filing$5.2M
  • Private capital raisedForm D · SEC · 6th filing$2.5M
  • Private capital raisedForm D · SEC · 5th filing$2.2M
  • Private capital raisedForm D · SEC · 4th filing$2.8M
  • Private capital raisedForm D · SEC · 3rd filing$3.4M
  • Private capital raisedForm D · SEC · 2nd filing$4.2M
  • Private capital raisedForm D · SEC · 1st filing$875K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#38 · top 9%
  • Granted patents#12 · top 3%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Chris CappelloResearcherExecutive Officer, DirectorLinked by 6 patents
  • Cody SmithDirectorNamed in SEC Form D filings
  • Gary CalmensonDirectorNamed in SEC Form D filings
  • Heather PottersExecutive Officer, DirectorNamed in SEC Form D filings
  • James BowmanExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeff JordanExecutive OfficerNamed in SEC Form D filings
Show all 25 people
  • Jeffrey JordanExecutive OfficerNamed in SEC Form D filings
  • John BuckleyDirectorNamed in SEC Form D filings
  • John (Spike) BuckleyDirectorNamed in SEC Form D filings
  • Kathy CallenderExecutive OfficerNamed in SEC Form D filings
  • Kevin LorenzDirectorNamed in SEC Form D filings
  • Kim DuncanDirectorNamed in SEC Form D filings
  • Linda SonntagDirectorNamed in SEC Form D filings
  • Marcus PedriksDirectorNamed in SEC Form D filings
  • Marian WentworthDirectorNamed in SEC Form D filings
  • Marie MazurDirectorNamed in SEC Form D filings
  • Markus PedricksDirectorNamed in SEC Form D filings
  • Markus PedriksDirectorNamed in SEC Form D filings
  • Maureen CullumExecutive OfficerNamed in SEC Form D filings
  • Mischa KowallDirectorNamed in SEC Form D filings
  • Paul MarcaccioDirectorNamed in SEC Form D filings
  • Rajen DalalExecutive Officer, DirectorNamed in SEC Form D filings
  • Rodney SmithDirectorNamed in SEC Form D filings
  • Ronald LowyExecutive Officer, DirectorNamed in SEC Form D filings
  • Tony AllardDirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 29
Show all 29 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .